Yuki Iwayanagi

Gotenba, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.

MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.

Journal: mAbs
Published: September 11, 2018

Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.

Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.

Journal: mAbs
Published: April 08, 2017

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.

Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.

Journal: Scientific reports
Published: December 21, 2016

Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.

Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.

Journal: Experimental dermatology
Published: September 27, 2016

Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation.

Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation.

Journal: mAbs
Published: October 27, 2015

PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model.

PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding model.

Journal: Drug metabolism and pharmacokinetics
Published: September 29, 2015

Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.

Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 10, 2014

Engineered monoclonal antibody with novel antigen-sweeping activity in vivo.

Engineered monoclonal antibody with novel antigen-sweeping activity in vivo.

Journal: PloS one
Published: October 31, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026